Cargando…
Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann–Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report
BACKGROUND: Niemann–Pick disease type C is a rare inherited neurodegenerative disease involving impaired intracellular lipid trafficking and accumulation of glycolipids in various tissues, including the brain. Miglustat, a reversible inhibitor of glucosylceramide synthase, has been shown to be effec...
Autores principales: | Cuisset, Jean-Marie, Sukno, S., Trauffler, A., Latour, P., Dobbelaere, D., Michaud, L., Vallée, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011888/ https://www.ncbi.nlm.nih.gov/pubmed/27599728 http://dx.doi.org/10.1186/s13256-016-1038-9 |
Ejemplares similares
-
Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C
por: Héron, Bénédicte, et al.
Publicado: (2012) -
Favorable outcomes following early onset oral miglustat in early infantile Niemann Pick Type C
por: Curelaru, Shiri, et al.
Publicado: (2021) -
Miglustat in Niemann-Pick disease type C patients: a review
por: Pineda, Mercè, et al.
Publicado: (2018) -
Use of miglustat in a child with late-infantile-onset Niemann-Pick disease type C and frequent seizures: a case report
por: Skorpen, Johannes, et al.
Publicado: (2012) -
Effects of miglustat therapy on neurological disorder and survival in early-infantile Niemann-Pick disease type C: a national French retrospective study
por: Freihuber, Cécile, et al.
Publicado: (2023)